Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB Clinical Trial to Evaluate the Effect of High-fat Diet on Pharmacokinetics of AL8326 Tablets in Chinese Healthy Adult Subjects

NCT05486598 is registered in ClinicalTrials.gov with Advenchen Laboratories Nanjing Ltd. as lead sponsor.

NCT NCT05486598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05486598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB Clinical Trial to Evaluate the Effect of High-fat Diet on Pharmacokinetics of AL8326 Tablets in Chinese Healthy Adult Subjects
Lead sponsor
Advenchen Laboratories Nanjing Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
June 21, 2022
Completion date
December 31, 2022
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diet, high-fat, pharmacokinetics